NASDAQ:AXSM | Cash Flow Statement | Axsome Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$51.31M
2026-03-31-$64.54M-$20.7M$121,000.00-$121,000.00$2.99M
2025-12-31-$28.56M-$18.65M$71,000.00-$71,000.00$16.39M
2025-09-30-$47.23M
2025-06-30-$47.97M
2025-03-31-$59.41M-$43.38M$338,000.00-$338,000.00$29.27M
2024-12-31-$74.91M-$26.2M$30,000.00-$30,000.00$14.24M
2024-09-30-$64.6M
2024-06-30-$79.35M
2024-03-31-$68.36M-$53.47M$98,000.00-$98,000.00-$1.19M
2023-12-31-$98.65M-$30.36M$7,000.00-$7,000.00-$2,000.00
2023-09-30-$62.2M
2023-06-30-$67.17M
2023-03-31-$11.22M-$5.82M$71,000.00-$71,000.00$51.57M
2022-12-31-$61.24M-$27.56M$181,000.00-$181,000.00$1.07M
2022-09-30-$44.82M
2022-06-30-$41.44M
2022-03-31-$39.63M-$32.65M$214,000.00-$214,000.00$31.1M
2021-12-31-$33.98M-$28.84M$451.00-$451.00$690,766.00
2021-09-30-$34.88M
2021-06-30-$32.28M
2021-03-31-$29.26M-$27.22M$29,995.00-$29,995.00$8.03M
2020-12-31-$29.16M-$20.55M$20,287.00-$20,287.00$2.09M
2020-09-30-$22.92M
2020-06-30-$18.33M
2020-03-31-$32.48M-$23.27M$9,331.00-$9,331.00$629,756.00
2019-12-31-$24.81M-$17.57M$1,461.00-$1,461.00$193.89M
2019-09-30-$19.14M
2019-06-30-$13.76M
2019-03-31-$10.64M-$9.5M$38.15M
2018-12-31-$9.6M-$9.79M$0.00$0.00$8.54M
2018-09-30-$8.28M
2018-06-30-$8.28M
2018-03-31-$4.81M-$6.68M$14,576.00-$14,576.00-$693,413.00
2017-12-31-$7.43M-$6.29M$1.00-$1.00$8.64M
2017-09-30-$6.43M
2017-06-30-$7.08M
2017-03-31-$8M-$6.64M$2,899.00-$2,899.00$15.04M
2016-12-31-$7.33M-$7.22M$6,055.00-$6,055.00$9.95M
2016-09-30-$7.19M
2016-06-30-$6.81M
2016-03-31-$5.87M-$3.95M$10,651.00-$10,651.00
2015-12-31-$3.36M-$2.25M$4,112.00-$4,112.00$45.67M
2015-09-30-$4.58M
2015-06-30-$2.13M
2015-03-31-$2.14M-$1.16M$10,256.00-$10,256.00$241,725.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$183.17M-$93.41M$480,000.00-$480,000.00$101.47M
2024-12-31-$287.22M-$128.41M$270,000.00-$270,000.00$57.84M
2023-12-31-$239.24M-$145.08M$582,000.00-$582,000.00$331.01M
2022-12-31-$187.13M-$116.51M$702,000.00-$53.7M$284.58M
2021-12-31-$130.4M-$108.23M$308,000.00-$308,000.00$11.13M
2020-12-31-$102.9M-$78.46M$45,891.00-$45,891.00$42.41M
2019-12-31-$68.35M-$46.38M$16,121.00-$16,121.00$252.39M
2018-12-31-$30.97M-$30.05M$32,696.00-$32,696.00$10.03M
2017-12-31-$28.94M-$26.47M$9,898.00-$9,898.00$23.88M
2016-12-31-$27.2M-$21.28M$104,561.00-$104,561.00$9.97M
2015-12-31-$12.21M-$7.44M$20,195.00-$20,195.00$52.88M
2014-12-31-$6M-$4.6M$5.13M